Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J GOLDBERGER

Showing results (11-20 of 288) with videos related to

Pageof 29
Sort By:
Cardiology Journal|January 29, 2014
Efficacy and tolerability of dronedarone for patients with atrial fibrillationTonye Teme, Jeffrey J Goldberger
Cardiology Journal|June 27, 2013
Atrial fibrillation practice patterns among cardiac electrophysiologists and cardiologistsTonye Teme, Jeffrey J Goldberger
Journal of the American College of Cardiology|November 21, 2009
Implantable cardioverter-defibrillator therapy after acute myocardial infarction: the results are not shockingJeffrey J Goldberger, Rod Passman
Expert Opinion on Investigational Drugs|November 4, 2000
Therapeutic developments in sudden cardiac deathJ J Goldberger, S Neelagaru
Current Treatment Options in Cardiovascular Medicine|December 20, 2011
Risk stratification for prevention of sudden cardiac deathPaban Saha, Jeffrey J Goldberger
Pacing and Clinical Electrophysiology : PACE|October 30, 2010
Pocket salvage in patients with infected device pocket and limited vascular access: a viable last resort?Justin Weiner, Jeffrey J Goldberger
Future Cardiology|July 10, 2013
Catheter ablation for supraventricular tachycardias: contemporary issuesEvaldas Giedrimas, Jeffrey J Goldberger
Current Cardiology Reports|August 13, 2004
Risk stratification and epidemiology of sudden deathSri Sundaram, Jeffrey J Goldberger
Journal of Clinical Pharmacology|July 1, 1989
Clinical utility of nifedipine and diltiazem plasma levels in patients with angina pectoris receiving monotherapy and combination treatmentJ Goldberger, W H Frishman
The American Journal of Cardiology|May 3, 2011
Implications of progressive aberrancy versus true fusion for diagnosis of wide complex tachycardiaEugene Greenstein, Jeffrey J Goldberger
Pageof 29

Showing results (11-20 of 288) with videos related to

Sort By:
Pageof 29
Cardiology Journal|January 29, 2014
Efficacy and tolerability of dronedarone for patients with atrial fibrillationTonye Teme, Jeffrey J Goldberger
Cardiology Journal|June 27, 2013
Atrial fibrillation practice patterns among cardiac electrophysiologists and cardiologistsTonye Teme, Jeffrey J Goldberger
Journal of the American College of Cardiology|November 21, 2009
Implantable cardioverter-defibrillator therapy after acute myocardial infarction: the results are not shockingJeffrey J Goldberger, Rod Passman
Expert Opinion on Investigational Drugs|November 4, 2000
Therapeutic developments in sudden cardiac deathJ J Goldberger, S Neelagaru
Current Treatment Options in Cardiovascular Medicine|December 20, 2011
Risk stratification for prevention of sudden cardiac deathPaban Saha, Jeffrey J Goldberger
Pacing and Clinical Electrophysiology : PACE|October 30, 2010
Pocket salvage in patients with infected device pocket and limited vascular access: a viable last resort?Justin Weiner, Jeffrey J Goldberger
Future Cardiology|July 10, 2013
Catheter ablation for supraventricular tachycardias: contemporary issuesEvaldas Giedrimas, Jeffrey J Goldberger
Current Cardiology Reports|August 13, 2004
Risk stratification and epidemiology of sudden deathSri Sundaram, Jeffrey J Goldberger
Journal of Clinical Pharmacology|July 1, 1989
Clinical utility of nifedipine and diltiazem plasma levels in patients with angina pectoris receiving monotherapy and combination treatmentJ Goldberger, W H Frishman
The American Journal of Cardiology|May 3, 2011
Implications of progressive aberrancy versus true fusion for diagnosis of wide complex tachycardiaEugene Greenstein, Jeffrey J Goldberger
Pageof 29